News
The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
A study reports that people living in lower income neighborhoods were at a higher risk for hidradenitis suppurativa.
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
Explore more
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...
Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 5.28%, which has investors questioning if this is right time to buy.
The ruling, seen as a major victory for transparency campaigners, piles pressure on Ursula von der Leyen over the opaque nature of the EU's vaccine negotiations during the pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results